Mentice AB (MNTC) - Net Assets
Based on the latest financial reports, Mentice AB (MNTC) has net assets worth Skr125.99 Million SEK (≈ $13.56 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr278.51 Million ≈ $29.97 Million USD) and total liabilities (Skr152.53 Million ≈ $16.41 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read Mentice AB (MNTC) financial obligations for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr125.99 Million |
| % of Total Assets | 45.24% |
| Annual Growth Rate | 16.73% |
| 5-Year Change | -12.0% |
| 10-Year Change | N/A |
| Growth Volatility | 32.89 |
Mentice AB - Net Assets Trend (2017–2024)
This chart illustrates how Mentice AB's net assets have evolved over time, based on quarterly financial data. Also explore Mentice AB asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for Mentice AB (2017–2024)
The table below shows the annual net assets of Mentice AB from 2017 to 2024. For live valuation and market cap data, see MNTC company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Skr143.66 Million ≈ $15.46 Million |
-9.63% |
| 2023-12-31 | Skr158.97 Million ≈ $17.11 Million |
-2.25% |
| 2022-12-31 | Skr162.63 Million ≈ $17.50 Million |
+18.81% |
| 2021-12-31 | Skr136.89 Million ≈ $14.73 Million |
-16.15% |
| 2020-12-31 | Skr163.25 Million ≈ $17.57 Million |
+30.85% |
| 2019-12-31 | Skr124.77 Million ≈ $13.43 Million |
+86.94% |
| 2018-12-31 | Skr66.74 Million ≈ $7.18 Million |
+37.21% |
| 2017-12-31 | Skr48.64 Million ≈ $5.23 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Mentice AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 267.9% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr1.28 Million | 0.89% |
| Other Comprehensive Income | Skr664.00K | 0.46% |
| Other Components | Skr201.73 Million | 140.42% |
| Total Equity | Skr143.66 Million | 100.00% |
Mentice AB Competitors by Market Cap
The table below lists competitors of Mentice AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Corem Property Group AB (publ)
ST:CORE-A
|
$38.44 Million |
|
Genoray Co. Ltd
KQ:122310
|
$38.45 Million |
|
Covalon Technologies Ltd.
V:COV
|
$38.48 Million |
|
Jinli Group Holdings Ltd
TW:8429
|
$38.51 Million |
|
Caprice Resources Ltd
AU:CRS
|
$38.43 Million |
|
Ihuman Inc
NYSE:IH
|
$38.41 Million |
|
Supercom Ltd
NASDAQ:SPCB
|
$38.40 Million |
|
OKYO PHARMA LTD SP.ADR/65
F:OK10
|
$38.38 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mentice AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 158,973,000 to 143,663,000, a change of -15,310,000 (-9.6%).
- Net loss of 18,420,000 reduced equity.
- Other comprehensive income increased equity by 2,094,999.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-18.42 Million | -12.82% |
| Other Comprehensive Income | Skr2.09 Million | +1.46% |
| Other Changes | Skr1.02 Million | +0.71% |
| Total Change | Skr- | -9.63% |
Book Value vs Market Value Analysis
This analysis compares Mentice AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.26x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 6.30x to 2.26x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | Skr2.01 | Skr12.70 | x |
| 2018-12-31 | Skr2.76 | Skr12.70 | x |
| 2019-12-31 | Skr6.38 | Skr12.70 | x |
| 2020-12-31 | Skr6.72 | Skr12.70 | x |
| 2021-12-31 | Skr5.53 | Skr12.70 | x |
| 2022-12-31 | Skr6.45 | Skr12.70 | x |
| 2023-12-31 | Skr6.22 | Skr12.70 | x |
| 2024-12-31 | Skr5.62 | Skr12.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mentice AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -12.82%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -6.34%
- • Asset Turnover: 0.90x
- • Equity Multiplier: 2.25x
- Recent ROE (-12.82%) is below the historical average (-4.55%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 12.71% | 5.67% | 1.16x | 1.93x | Skr1.32 Million |
| 2018 | 30.19% | 12.83% | 1.20x | 1.96x | Skr13.47 Million |
| 2019 | -16.51% | -13.79% | 0.80x | 1.50x | Skr-33.08 Million |
| 2020 | -8.02% | -9.52% | 0.56x | 1.50x | Skr-29.42 Million |
| 2021 | -21.32% | -15.77% | 0.71x | 1.91x | Skr-42.88 Million |
| 2022 | -18.86% | -14.07% | 0.65x | 2.05x | Skr-46.93 Million |
| 2023 | -1.77% | -1.03% | 0.85x | 2.03x | Skr-18.71 Million |
| 2024 | -12.82% | -6.34% | 0.90x | 2.25x | Skr-32.79 Million |
Industry Comparison
This section compares Mentice AB's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $412,422,346
- Average return on equity (ROE) among peers: -62.28%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mentice AB (MNTC) | Skr125.99 Million | 12.71% | 1.21x | $38.44 Million |
| Acarix A/S (ACARIX) | $76.60 Million | -60.65% | 0.08x | $33.84 Million |
| Arcoma AB (ARCOMA) | $59.33 Million | 18.84% | 0.36x | $11.55 Million |
| Bactiguard Holding AB (publ) (BACTI-B) | $353.18 Million | -39.18% | 0.87x | $61.64 Million |
| BICO Group AB (BICO) | $3.01 Billion | -0.18% | 0.82x | $159.82 Million |
| Boule Diagnostics AB (BOUL) | $119.08 Million | 0.00% | 0.39x | $14.38 Million |
| CellaVision AB (CEVI) | $429.62 Million | 20.83% | 0.55x | $311.10 Million |
| Clinical Laserthermia Systems AB (publ) (CLS-B) | $19.46 Million | -85.28% | 0.14x | $11.57 Million |
| Chordate Medical Holding AB (CMH) | $18.24 Million | -128.06% | 0.60x | $29.05K |
| C-Rad AB (publ) (CRAD-B) | $35.05 Million | -30.59% | 0.38x | $86.08 Million |
| Duearity AB (DEAR) | $6.06 Million | -318.56% | 0.99x | $331.97K |
About Mentice AB
Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedura… Read more